The authors hypothesized that this expansion of FoxP3+ cells in early SSc skin may reflect a regulatory feedback mechanism to restore cellular tolerance and ameliorate harmful autoimmune responses. The gene discussed is FOXP3; the disease is systemic sclerosis.